Vagal Afferents Mediate Early Satiation and Prevent Flavour Avoidance Learning in Response to Intraperitoneally Infused Exendin-4

Journal of Neuroendocrinology

Volumn 24, Issue 12, 2012, Pages 1505-1516

  Labouesse, M A ^a   Stadlbauer, U ^a   Weber, E ^a   Arnold, M ^a   Langhans, W ^a   Pacheco Lopez G ^a,b  

^a ETH ZURICH   (Switzerland)

^b Metroipolitan Autonomous University Lerma   (Mexico)

Author keywords

Avoidance learning; C Fos; Food intake; Meal pattern; Subdiaphragmatic vagal deafferentation

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; PROTEIN C FOS;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONDITIONED REFLEX; FLAVOR; FOOD INTAKE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SATIETY; SHAM PROCEDURE; THALAMUS VENTRAL NUCLEUS; VAGUS NERVE; VAGUS NERVE DORSAL NUCLEUS;

AFFERENT PATHWAYS; ANIMALS; AVOIDANCE LEARNING; BRAIN; DRUG EVALUATION, PRECLINICAL; EATING; FEEDING BEHAVIOR; HYPOGLYCEMIC AGENTS; INFUSIONS, PARENTERAL; MALE; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SATIATION; TASTE; VAGUS NERVE; VENOMS;

EID: 84869788004     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02364.x     Document Type: Article

References (59)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431-1437.
2. Torekov SS, Madsbad S, Holst JJ. Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential. Obes Rev 2011; 12: 593-601.
3. Chelikani PK, Haver AC, Reidelberger RD. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Am J Physiol 2005; 288: R1695-R1706.
4. Scott KA, Moran TH. The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size. Am J Physiol 2007; 293: R983-R987.
5. Ruttimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 2009; 150: 1174-1181.
6. Gutzwiller JP, Goke B, Drewe J, Hildebrand P, Ketterer S, Handschin D, Winterhalder R, Conen D, Beglinger C. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999; 44: 81-86.
7. Barrera JG, Sandoval DA, D'Alessio DA, Seeley RJ. GLP-1 and energy balance: an integrated model of short-term and long-term control. Nat Rev Endocrinol 2011; 7: 507-516.
8. Estall JL, Drucker DJ. Glucagon and glucagon-like peptide receptors as drug targets. Curr Pharm Des 2006; 12: 1731-1750.
9. Hayes MR, Kanoski SE, Alhadeff AL, Grill HJ. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats. Obesity (Silver Spring) 2011; 19: 1342-1349.
10. Mack CM, Moore CX, Jodka CM, Bhavsar S, Wilson JK, Hoyt JA, Roan JL, Vu C, Laugero KD, Parkes DG, Young AA. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Int J Obes (Lond) 2006; 30: 1332-1340.
11. Naslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rossner S, Hellstrom PM. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord 1999; 23: 304-311.
12. Gutzwiller JP, Drewe J, Goke B, Schmidt H, Rohrer B, Lareida J, Beglinger C. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol 1999; 276: R1541-R1544.
13. Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. Endocrinology 2011; 152: 3103-3112.
14. Baraboi ED, St-Pierre DH, Shooner J, Timofeeva E, Richard D. Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4. Am J Physiol 2011; 301: R1011-R1024.
15. Washington MC, Raboin SJ, Thompson W, Larsen CJ, Sayegh AI. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor. Brain Res 2010; 1344: 124-133.
16. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005; 146: 3748-3756.
17. Punjabi M, Arnold M, Geary N, Langhans W, Pacheco-Lopez G. Peripheral glucagon-like peptide-1 (GLP-1) and satiation. Physiol Behav 2011; 105: 71-76.
18. Berthoud HR, Blackshaw LA, Brookes SJ, Grundy D. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 2004; 16: 28-33.
19. Williams DL, Baskin DG, Schwartz MW. Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology 2009; 150: 1680-1687.
20. Hayes MR, Kanoski SE, De Jonghe BC, Leichner TM, Alhadeff AL, Fortin SM, Arnold M, Langhans W, Grill HJ. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. Am J Physiol 2011; 301: R1479-R1485.
21. Berthoud HR. The vagus nerve, food intake and obesity. Regul Pept 2008; 149: 15-25.
22. Hunt JV, Washington MC, Sayegh AI. Exenatide and feeding: possible peripheral neuronal pathways. Peptides 2012; 33: 285-290.
23. Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 2007; 298: 194-206.
24. Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC, Hayes MR. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology 2012; 62: 1916-1927.
25. Norgren R, Smith GP. A method for selective section of vagal afferent or efferent axons in the rat. Am J Physiol 1994; 267: R1136-R1141.
26. Arnold M, Mura A, Langhans W, Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 2006; 26: 11052-11060.
27. Smith GP, Jerome C, Norgren R. Afferent axons in abdominal vagus mediate satiety effect of cholecystoskinin in rats. Am J Physiol 1985; 249: R638-R641.
28. Ackroff K, Sclafani A. Conditioned flavor preferences: evaluating postingestive reinforcement by nutrients. Curr Protoc Neurosci 2001; Chapter 8: Unit 8.6F.
29. Rinaman L, Dzmura V. Experimental dissociation of neural circuits underlying conditioned avoidance and hypophagic responses to lithium chloride. Am J Physiol 2007; 293: R1495-R1503.
30. Pacheco-López G, Espinosa E, Zamorano-Rojas HM, Ramírez-Amaya V, Bermúdez-Rattoni F. Peripheral protein immunization induces rapid activation of the CNS, as measured by c-Fos expression. J Neuroimmunol 2002; 131: 50-59.
31. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 6th edn. San Diego, CA: Academic Press, 2007.
32. Hayes MR, Bradley L, Grill HJ. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 2009; 150: 2654-2659.
33. Burke S. Missing values, outliers, robust statistics & non-parameteric methods. LG-GC Europe Online Supplement http://www.lcgceurope.com/lcgceurope/data/articlestandard/lcgceurope/502001/4509/article.pdf.
34. Kraly FS, Jerome C, Smith GP. Specific postoperative syndromes after total and selective vagotomies in the rat. Appetite 1986; 7: 1-17.
35. McKay NJ, Kanoski SE, Hayes MR, Daniels D. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake. Am J Physiol 2011; 301: R1755-R1764.
36. Asarian L. Loss of cholecystokinin and glucagon-like peptide-1-induced satiation in mice lacking serotonin 2C receptors. Am J Physiol 2009; 296: R51-R56.
37. Zhang J, Ritter RC. Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms. Am J Physiol 2012; 302: R264-R273.
38. Berthoud HR. Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev 2002; 26: 393-428.
39. Hayes MR, Skibicka KP, Grill HJ. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology 2008; 149: 4059-4068.
40. Krukoff TL. C-fos expression as a marker of functional activity in the brain. In: Boulton AA, Baker GB, Bateson AN, eds. Neuromethods, Cell Neurobiology Techniques. Totowa (New Jersey): Humana Press 1999; 33: 213-230.
41. Tang-Christensen M, Vrang N, Mollet A, Gilg S, Lykkegaard K-A, Bloch-Thomsen A, Larsen OJ, Lutz TA. Peripheral Administration of Exendin-4 Activates Neurons in Hindbrain and Forebrain Areas and Causes the Formation of a Conditioned Taste Aversion. Orlando, FL, USA: Society for Neuroscience Annual Meeting, 2002.
42. Kinzig KP, D'Alessio DA, Seeley RJ. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci 2002; 22: 10470-10476.
43. van Dijk G, Thiele TE. Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress. Neuropeptides 1999; 33: 406-414.
44. McMahon LR, Wellman PJ. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am J Physiol 1998; 274: R23-R29.
45. Alhadeff AL, Rupprecht LE, Hayes MR. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 2012; 153: 647-658.
46. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011; 12: 453-466.
47. Chen SL, Wu XY, Cao ZJ, Fan J, Wang M, Owyang C, Li Y. Subdiaphragmatic vagal afferent nerves modulate visceral pain. Am J Physiol 2008; 294: G1441-G1449.
48. Gschossmann JM, Mayer EA, Miller JC, Raybould HE. Subdiaphragmatic vagal afferent innervation in activation of an opioidergic antinociceptive system in response to colorectal distension in rats. Neurogastroenterol Motil 2002; 14: 403-408.
49. Furuta S, Shimizu T, Narita M, Matsumoto K, Kuzumaki N, Horie S, Suzuki T. Subdiaphragmatic vagotomy promotes nociceptive sensitivity of deep tissue in rats. Neuroscience 2009; 164: 1252-1262.
50. Thiele TE, Seeley RJ, D'Alessio D, Eng J, Bernstein IL, Woods SC, van Dijk G. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem. Brain Res 1998; 801: 164-170.
51. Gaykema RP, Daniels TE, Shapiro NJ, Thacker GC, Park SM, Goehler LE. Immune challenge and satiety-related activation of both distinct and overlapping neuronal populations in the brainstem indicate parallel pathways for viscerosensory signaling. Brain Res 2009; 1294: 61-79.
52. Rinaman L. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation. J Neurosci 2003; 23: 10084-10092.
53. Sutton RL, Fox RA, Daunton NG. Role of the area postrema in three putative measures of motion sickness in the rat. Behav Neural Biol 1988; 50: 133-152.
54. Bahar A, Samuel A, Hazvi S, Dudai Y. The amygdalar circuit that acquires taste aversion memory differs from the circuit that extinguishes it. Eur J Neurosci 2003; 17: 1527-1530.
55. Bures J, Bermudez-Rattoni F, Yamamoto T. Conditioned Taste Aversion: Memory of a Special Kind. Oxford: Oxford University Press, 1998; Chapter 2.
56. Yamamoto H. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest 2002; 110: 43-52.
57. Baumgartner I, Pacheco-Lopez G, Ruttimann EB, Arnold M, Asarian L, Langhans W, Geary N, Hillebrand JJ. Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats. J Neuroendocrinol 2010; 22: 557-563.
58. Dossat AM, Lilly N, Kay K, Williams DL. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J Neurosci 2011; 31: 14453-14457.
59. Dickson SL, Shirazi RH, Caroline HC, Bergquist F, Nissbrandt H, Skibicka KP. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 2012; 32: 4812-4820.